메뉴 건너뛰기

R&D

Innovation and creating sustainable values

Pipleline

Mesenchymal stem cells

HL401 Systemic Lupus Erythematosus

NCE (New chemical Entity) Discovery

HL301 Acute Bronchitis, HL2017 AMD, HL237 Rheumatoid Arthritis

IMD (Incrementally modified drug)

Lumino-mark Inj. Breast Cancer Surgery marker, HL Tofacitinib Reumatoid Arthritis